Pharmaceutical Industries
Business  /  Published 12.08.19

The inside story of Ranbaxy's dirty drugs scandal

Kumar’s document explained that while the company had slashed production costs and used the cheapest ingredients in those markets, it submitted data from the drugs that had been made for more regula...
By Katherine Eban in

Business  /  Published 22.01.19

Sun Pharma tries to limit damage

By Our Bureau in Mumbai

Business  /  Published 22.09.19

Dr. Reddy's halts global supply of ranitidine

Dr Reddy's Laboratories Limited on Sunday said that it is suspending supply of its drug ranitidine worldwide as a precautionary measure, following the ongoing probe by the US Food and Drug Administrat...
By PTI in Hyderabad

Opinion  /  Published 31.07.19

Dangerous drugs, compromised regulators

The average consumer of medication in this country does not lose much sleep over drug quality or how drug regulators are doing their job. A new book out in the United States and now available here co...
By Sevanti Ninan in

Business  /  Published 30.03.20

Curbs on Sun Pharma

The shares of Sun Pharmaceutical Industries ended lower on the bourses on Monday after the company said that the US drug regulator may not give the green signal for the export of new products from its...
By Our Special Correspondent in Mumbai

Opinion  /  Published 08.05.19

Rise in drug-resistant diseases threatens India

The world could well be returning to the dark ages before penicillin when even ordinary soil bacteria could slay the weak at will. The latest report of the United Nations Interagency Coordination Grou...
By The Editorial Board in

India  /  Published 28.01.20

Pharma industry likely to grow at 10-13 pc

The growth trajectory for the Indian pharmaceutical industry is likely to remain at 10-13 per cent in 2020-21 despite challenges, according to rating agency Icra.The expected growth in the next financ...
By PTI in New Delhi

Books  /  Published 12.10.19

Rise and fall of Malvinder Singh

He assumed his new role as CEO with ease. His management style was brash, competitive, and ambitious. Malvinder immediately looked around the globe for opportunity. The fawning Indian business press d...
By Katherine Eban in

Business  /  Published 13.03.20

Sun Pharma to consider buyback

Shares of Sun Pharmaceutical Industries rallied over 8 per cent a day after the company informed that its board will be meeting next week to discuss a proposal for buyback of shares.On the BSE, the Su...
By Our Special Correspondent in Mumbai

Business  /  Published 03.12.18

Sun Pharma bid to limit damage

Dilip Shanghvi, the founder and managing director of Sun Pharmaceutical Industries, on Monday indicated the company was open to taking a relook at some of the earlier transactions or decisions in the ...
By Our Special Correspondent in Mumbai


Download our latest App

to get update on the go...


Copyright © 2020 The Telegraph. All rights reserved.